NovoRapid Penfill 3mL

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
26-05-2024

Aktiivinen ainesosa:

Insulin aspart

Saatavilla:

Novo Nordisk Pharmaceuticals Pty Ltd

luokka:

Medicine Registered

Pakkausseloste

                                 
NovoRapid
®
 Penfill
® 
 
Page 1 of 6 
NovoRapidPfcmi14.doc 
NOVORAPID
®
 PENFILL
®
  
_Insulin aspart (rys) _
CONSUMER MEDICINE INFORMATION 
 
WHAT IS IN THIS LEAFLET 
WHAT NOVORAPID
®
 IS USED FOR.. 1
 
BEFORE YOU USE NOVORAPID
®
 
PENFILL
®
....................................... 1
 
HOW TO USE NOVORAPID
®
 PENFILL
®
  2
 
WHILE YOU ARE USING NOVORAPID
®
 
PENFILL
®
....................................... 4
 
THINGS TO BE CAREFUL OF ............. 5
 
SIDE EFFECTS................................. 5
 
AFTER USING NOVORAPID
®
 PENFILL
®
  6
 
PRODUCT DESCRIPTION ................. 6
 
FURTHER INFORMATION ................ 6
 
This leaflet answers some common 
questions about NovoRapid
®
 
Penfill
®
. It does not contain all the 
available information.  It does not 
take the place of talking to your 
doctor, diabetes education nurse or 
pharmacist. 
All medicines have risks and 
benefits.  Your doctor has weighed 
the risks of you using NovoRapid
®
 
Penfill
®
 against the benefits they 
expect it will have for you. 
IF YOU HAVE ANY CONCERNS ABOUT 
USING THIS MEDICINE, ASK YOUR 
DOCTOR, DIABETES EDUCATION NURSE 
OR PHARMACIST. 
KEEP THIS LEAFLET WITH THE MEDICINE.
  
You may need to read it again.
 
WHAT NOVORAPID
®
 IS 
USED FOR 
The insulin aspart, or 
“NovoRapid
®
”, in NovoRapid
®
 
Penfill
®
 is a rapid-acting insulin used 
to treat diabetes mellitus in adults 
and children. Diabetes  mellitus is a 
condition where your pancreas does 
not produce enough insulin to 
control your blood sugar (glucose) 
level.  Extra insulin is therefore 
needed. 
There are two types of diabetes 
mellitus: 
Type 1 diabetes – also called 
juvenile onset diabetes 
Type 2 diabetes – also called 
maturity onset diabetes 
Patients with type 1 diabetes always 
require insulin to control their blood 
sugar levels. 
Some patients with type 2 diabetes 
may also require
                                
                                Lue koko asiakirja
                                
                            

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia